Genetic variants in IL2RA and IL7R affect multiple sclerosis disease risk and progression

Neurogenetics

Volumn 15, Issue 3, 2014, Pages 165-169

  Traboulsee, Anthony L ^a   Bernales, Cecily Q ^b   Ross, Jay P ^b   Lee, Joshua D ^b   Sadovnick, A Dessa ^a,b   Vilariño Güell, Carles ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Association; IL2RA; IL7R; Multiple sclerosis; Progressive disease

Indexed keywords

INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; IL2RA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FAMILY HISTORY; FEMALE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; POWER ANALYSIS; PRIORITY JOURNAL; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; CANADA; GENETIC ASSOCIATION; GENETICS; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; CANADA; DISEASE PROGRESSION; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RECEPTORS, INTERLEUKIN-7; RISK FACTORS;

EID: 84904559834     PISSN: 13646745     EISSN: 13646753     Source Type: Journal    
DOI: 10.1007/s10048-014-0403-3     Document Type: Article

References (26)

1. Wade BJ (2014) Spatial analysis of global prevalence of multiple sclerosis suggests need for an updated prevalence scale. Mult Scler Int 2014:124578. doi:10.1155/2014/124578
2. Ebers GC (2008) Environmental factors and multiple sclerosis. Lancet Neurol 7(3):268-277
3. Noseworthy JH (1999) Progress in determining the causes and treatment of multiple sclerosis. Nature 399(6738 Suppl):A40-A47
4. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L et al (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476(7359):214-219. doi:10.1038/ nature10251
5. Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C et al (2013) Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 45(11):1353-1360. doi:10.1038/ng.2770
6. Gregory SG, Schmidt S, Seth P, Oksenberg JR, Hart J, Prokop A et al (2007) Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional associationwithmultiple sclerosis. Nat Genet 39(9):1083-1091. doi:10.1038/ng2103 (Pubitemid 47340652)
7. Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL et al (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357(9):851-862. doi:10.1056/NEJMoa073493 (Pubitemid 47347319)
8. Wang LM, Zhang DM, Xu YM, Sun SL (2011) Interleukin 2 receptor alpha gene polymorphism and risk of multiple sclerosis: a meta-analysis. J Int Med Res 39(5):1625-1635
9. Zhang R, Duan L, Jiang Y, Zhang X, Sun P, Li J, Zhang M, Tang G, Wang X, Li X (2011) Association between the IL7RT244I polymorphism and multiple sclerosis: a meta-analysis. Mol Biol Rep 38(8):5079-5084. doi:10.1007/s11033- 010-0654-5
10. Hoppenbrouwers IA, Aulchenko YS, Janssens AC, Ramagopalan SV, Broer L, Kayser M, Ebers GC, Oostra BA, van Duijn CM, Hintzen RQ (2009) Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis. J Hum Genet 54(11):676-680. doi:10.1038/jhg.2009.96
11. Akkad DA, Hoffjan S, Petrasch-Parwez E, Beygo J, Gold R, Epplen JT (2009) Variation in the IL7RA and IL2RA genes in German multiple sclerosis patients. J Autoimmun 32(2):110-115. doi:10.1016/j.jaut.2009.01.002
12. Sadovnick AD, Risch NJ, Ebers GC (1998) Canadian collaborative project on genetic susceptibility to MS, phase 2: rationale and method. Canadian Collaborative Study Group. Can J Neurol Sci 25(3):216-221 (Pubitemid 28368797)
13. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13(3):227-231. doi:10.1002/ana.410130302 (Pubitemid 13158528)
14. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 50(1):121-127
15. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58(6):840-846. doi:10.1002/ana.20703 (Pubitemid 41746873)
16. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444-1452
17. Trinh J, Vilarino-Guell C, Donald A, Shah B, Yu I, Szu-Tu C, Aasly JO, Wu RM, Hentati F, Rajput AH, Rajput A, Farrer MJ (2013) STX6 rs1411478 is not associated with increased risk of Parkinson's disease. Parkinsonism Relat Disord 19(5):563-565. doi:10.1016/j.parkreldis.2013.01.019
18. Jiang Q, Li WQ, Aiello FB, Mazzucchelli R, Asefa B, Khaled AR, Durum SK (2005) Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev 16(4-5):513-533 (Pubitemid 41022015)
19. Malek TR, Bayer AL (2004) Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 4(9):665-674. doi:10.1038/nri1435 (Pubitemid 39223073)
20. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ et al (2009) Finding the missing heritability of complex diseases. Nature 461(7265):747-753. doi:10.1038/nature08494
21. Booth DR, Arthur AT, Teutsch SM, Bye C, Rubio J, Armati PJ, Pollard JD, Heard RN, Stewart GJ (2005) Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressivemultiple sclerosis. J Mol Med (Berlin) 83(10):822-830. doi:10.1007/s00109-005-0684-y (Pubitemid 41407866)
22. Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallstrom E, Khademi M, Oturai A, Ryder LP, Saarela J, Harbo HF, Celius EG, Salter H, Olsson T, Hillert J (2007) Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet 39(9):1108-1113 (Pubitemid 47340654)
23. Zhang Z, Duvefelt K, Svensson F, Masterman T, Jonasdottir G, Salter H, Emahazion T, Hellgren D, Falk G, Olsson T, Hillert J, Anvret M (2005) Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis. Genes Immunol 6(2):145-152 (Pubitemid 40439541)
24. Qiu W, Pham K, James I, Nolan D, Castley A, Christiansen FT, Czarniak P, Luo Y, Wu J, Garlepp M, Wilton S, Carroll WM, Mastaglia FL, Kermode AG (2013) The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort. J Neuroimmunol 261(1-2):92-97. doi:10.1016/j.jneuroim.2013.04.022
25. O'Doherty C, Kantarci O, Vandenbroeck K (2008) IL7RA polymorphisms and susceptibility to multiple sclerosis. N Engl JMed 358(7):753-754. doi:10.1056/NEJMc0707553 (Pubitemid 351240775)
26. McKay FC, Swain LI, Schibeci SD, Rubio JP, Kilpatrick TJ, Heard RN, Stewart GJ, Booth DR (2008) CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosis. J Autoimmun 31(1):52-58. doi:10.1016/j.jaut.2008.02.003